Rituximab is associated with improved survival in cardiac allograft patients with antibody-mediated rejection: a single center review.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ashwin Ravichandran |
| Publication date | November 9, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |